IX

Inform Exploration Corp. (TSX VENTURE:IX) ("Inform" or the "Company") is pleased
to announce that it has entered into an interim agreement effective May 14, 2014
to acquire (the "Acquisition") all of the issued and outstanding securities of
OrganiGram Inc. ("OGI"), an arms'-length private New Brunswick licensed producer
of medical marihuana. 


The Acquisition is expected to be structured as a Reverse Takeover ("RTO") under
the rules and policies of the TSX Venture Exchange. The shareholders of OGI will
receive common shares of the Company (the "Inform Shares") in exchange for their
common shares of OGI (the "OGI Shares") on the basis of 34,500,000 Inform Shares
at a deemed price of $0.85 per share in exchange for 18,678,496 OGI Shares (the
"Share Exchange"). The interim agreement has been entered into shareholders
comprising 67% of the shareholders of OGI. 


In connection with the Acquisition, the Company will undertake a brokered equity
financing (the "Concurrent Financing") of common shares for gross proceeds of
not less than $3,000,000 for a total of 3,529,411 shares. The use of proceeds of
the Concurrent Financing will be for facilities development, marketing and
working capital. 


Pursuant to the interim agreement, the Company has arranged a third party bridge
loan of $1,000,000 (the "Bridge Loan") to be used by OGI to fund the
construction and development of the OGI marihuana growing facility, including
the expansion of the number of lights and consequent growing capacity. The
Bridge Loan will bear interest at an annual rate of 8%, and will be fully
repayable by OGI to the Bridge Loan lender in the event that the Share Exchange
is not completed, and is otherwise convertible into the Concurrent Financing.
Repayment of the Bridge Loan will be secured through a grant of a registerable,
first-ranking security interest in and to all present and after acquired
personal property of OGI, including security over revenues from its license to
produce medical marihuana. 


Prior to the Share Exchange, the Company will effect a consolidation of the
Inform Shares (the "Consolidation") on an approximately 0.8836 to 1 basis,
resulting in 7,327,204 Inform Shares being issued and outstanding on closing
based on 8,292,400 Inform Shares being issued and outstanding as of the date
hereof. All outstanding options to acquire common shares of Inform will be
cancelled and replaced with new options issued upon closing the Acquisition in
amounts and with exercise prices at the discretion of the board of directors
having regard to the policies of the TSX Venture Exchange (the "TSX-V"). 


After the Share Exchange and Concurrent Financing, the Company is expected to
have 45,356,615 common shares issued and outstanding based on the current
capital structure of OGI and the Company, with current shareholders of OGI
holding approximately 76% of the issued shares post closing and the current
shareholders of Inform together with the Concurrent Financing shareholders
holding approximately 24% of the issued shares. Following closing the Company
will be engaged in the licensed production of medical marihuana. 


The interim agreement contemplates material conditions precedent to be fulfilled
prior to there being a binding agreement between the Company and OGI, including
customary due diligence, the negotiation and execution of a definitive agreement
and board approvals being obtained. Until satisfaction of these and other
conditions precedent, the likelihood of closing the transaction is uncertain and
trading in the securities of the Company would be highly speculative. Completion
of the Acquisition is subject to a number of conditions, including, but not
limited to the receipt of all necessary regulatory, corporate and third party
approvals, compliance with all applicable regulatory requirements, and the
completion of the Concurrent Financing for gross proceeds of not less than
$3,000,000. Further disclosure concerning the terms and conditions of the
Acquisition, including management, directors and advisors will be disclosed once
the conditions precedent have been fulfilled and a definitive agreement is
entered into. 


Trading in the Company's shares has been halted in compliance with the RTO
policies of the TSX-V. 


"This transaction is an important and exciting step in the development of our
company", said Jim Laffoley, President and Founder of OrganiGram Inc, adding,
"It will provide the company with resources necessary to be a leading supplier
of Condition Specific, Organically grown, Medical Marijuana in Canada as well as
enabling us to extend and pursue partnerships throughout North America and
internationally that assures patients and physicians of the quality, security
and availability of our products". 


Medical marihuana has been legally available to Canadians upon the advice of a
physician since 2001. Previously, medical marijuana was only available to
individuals by applying for access to Health Canada's supplies, obtaining a
personal-use production license, or designating a third party to cultivate
marihuana on their behalf under license. With the introduction of the Marihuana
for Medical Purposes Regulations, the Government of Canada has enabled the
establishment of commercial marihuana production and sale by licensed producers.
 


OGI became a licensed producer of medical marijuana on March 26, 2014. OGI
carries out its principal activities producing and selling marijuana from its
facilities in Moncton, New Brunswick pursuant to the provisions of the Marihuana
for Medical Purposes Regulations and the Controlled Drugs and Substances Act and
its regulations. 


Inform was incorporated under the Business Corporations Act (British Columbia)
and is publicly traded reporting issuer listed on the TSX-V. Inform was formerly
engaged in the acquisition, exploration and development of natural resource
properties and will cease all resource exploration activity concurrent with the
Transaction. 


Inform Exploration anticipates seeking an exemption for the sponsorship
requirements of the TSX-V in connection with the transaction, however no
assurance can be given that such exemption will be granted. 


Completion of the proposed transaction is subject to a number of conditions,
including TSX-V acceptance and disinterested shareholder approval. The
transaction cannot close until the required shareholder approval is obtained.
There can be no assurance that the transaction will be completed as proposed or
at all.


Investors are cautioned that, except as disclosed in the Filing Statement to be
prepared in connection with the transaction, any information released or
received with respect to the RTO may not be accurate or complete and should not
be relied upon. Trading in securities of Inform Exploration Corp. should be
considered highly speculative.


The TSX Venture Exchange Inc. has in no way passed upon the merits of the
proposed transaction and has neither approved nor disapproved the contents of
this press release.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accep ts responsibility
for the adequacy or accuracy of this release.


This news release contains forward-looking information, which involves known and
unknown risks, uncertainties and other factors that may cause actual events to
differ materially from current expectation. Important factors - including the
availability of funds, the results of financing efforts, the results of
exploration activities -- that could cause actual results to differ materially
from the Company's expectations are disclosed in the Company's documents filed
from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of
the date of this press release. The company disclaims any intention or
obligation, except to the extent required by law, to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Inform Exploration Corp.
Aaron Keay
Director
(604) 323-6911


Inform Exploration Corp.
David Doherty
President
604-315-1237


OrganiGram Inc
Jim Laffoley
President & Founder
1-855-961-9420

(TSXV:IX)
Historical Stock Chart
From May 2024 to Jun 2024

(TSXV:IX)
Historical Stock Chart
From Jun 2023 to Jun 2024